GENNIEFY
Market News
Latest financial news and analysis from global markets
SNOW
How The Snowflake (SNOW) Investment Narrative Is Shifting With AI Hopes And Valuation Risks
Snowflake’s fair value estimate has been trimmed slightly from US$236.61 to US$232.74 per share, a move of about US$4 or roughly 1.6%. That modest pullback lines up with Street research that is resetting price targets after the Q4 update, balancing solid execution and AI related tailwinds against valuation sensitivity and high expectations. As you read on, you will see how this evolving analyst narrative can inform how you track the stock’s risk and reward profile over time. Stay updated as...
BTCUSDT
Strategy's $67 Billion Bitcoin Stance Starts To Shift
Strategy says it could sell Bitcoin if the move improves capital structure or increases Bitcoin per share.
MS
Cerebras IPO Demand Tops $10 Billion As AI Chip Listing Heats Up
Cerebras is seeking up to $3.5 billion as banks request limit orders from institutional IPO investors.
INTC
Cerebras IPO Demand Tops $10 Billion As AI Chip Listing Heats Up
Cerebras is seeking up to $3.5 billion as banks request limit orders from institutional IPO investors.
ZM
Does Zoom Look Undervalued At 18x Earnings?
Is Zoom Communications stock (NASDAQ: ZM) pricey at 18 times earnings? Not at all.
CRM
Does Zoom Look Undervalued At 18x Earnings?
Is Zoom Communications stock (NASDAQ: ZM) pricey at 18 times earnings? Not at all.
GOOGL
Does Zoom Look Undervalued At 18x Earnings?
Is Zoom Communications stock (NASDAQ: ZM) pricey at 18 times earnings? Not at all.
MSFT
Does Zoom Look Undervalued At 18x Earnings?
Is Zoom Communications stock (NASDAQ: ZM) pricey at 18 times earnings? Not at all.
PFE
Pfizer CEO Backs Trump's CDC Pick After Vaccine Policy Upheaval
Pfizer (NYSE:PFE) chief executive Albert Bourla has signaled a possible shift in tone around US vaccine policy, praising President Donald Trump's latest nominee to lead the Centers for Disease Control and Prevention after a turbulent year for the agency. In a Bloomberg TV interview Tuesday, Bourla called Erica Schwartz a very credible scientist, pointing to what could be a more conventional choice for the country's top public health role. Schwartz, who holds both medical and law degrees and previously served as deputy surgeon general during the first Trump administration, is now being viewed as a figure who could help stabilize an agency that has become increasingly important for vaccine makers.
GOOGL
Anthropic to rent all AI capacity at SpaceX's Colossus data center
Anthropic says it will rent all of the compute capacity from SpaceX's massive Colossus 1 data center.
AMZN
Anthropic to rent all AI capacity at SpaceX's Colossus data center
Anthropic says it will rent all of the compute capacity from SpaceX's massive Colossus 1 data center.
NVDA
Anthropic to rent all AI capacity at SpaceX's Colossus data center
Anthropic says it will rent all of the compute capacity from SpaceX's massive Colossus 1 data center.